N-Q 1 form.htm FORM NQ-026 form
    UNITED STATES 
    SECURITIES AND EXCHANGE COMMISSION 
    Washington, D.C. 20549 
 
 
    FORM N-Q 
 
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT 
    INVESTMENT COMPANY 
 
Investment Company Act file number 811-0523 
 
    DREYFUS FUND INCORPORATED 
    (Exact name of Registrant as specified in charter) 
 
 
    c/o The Dreyfus Corporation 
    200 Park Avenue 
    New York, New York 10166 
    (Address of principal executive offices) (Zip code) 
 
    Mark N. Jacobs, Esq. 
    200 Park Avenue 
    New York, New York 10166 
    (Name and address of agent for service) 
 
Registrant's telephone number, including area code: (212) 922-6000 
 
Date of fiscal year end:    12/31 
 
Date of reporting period:    3/31/06 


FORM N-Q

Item 1. Schedule of Investments.

STATEMENT OF INVESTMENTS     
The Dreyfus Fund Incorporated     
March 31, 2006 (Unaudited)         
 
 
Common Stocks--99.9%    Shares    Value ($) 



Basic Industries--1.8%         
Air Products & Chemicals    100,000    6,719,000 
E I Du Pont de Nemours & Co.    225,000    9,497,250 
Galen Partners II, LP    1.142 d    769,196 
SK Equity Fund, LP    1.788 d    8,852,879 
        25,838,325 
Capital Goods--10.4%         
Caterpillar    122,000    8,760,820 
Corning    426,400 a    11,474,424 
Eaton    163,900    11,959,783 
Emerson Electric    226,930    18,978,156 
General Electric    1,570,000    54,604,600 
H & R Block    267,000    5,780,550 
Johnson Controls    124,100    9,422,913 
Tyco International    427,100    11,480,448 
United Technologies    260,500    15,101,185 
        147,562,879 
Consumer Non-Durables--9.4%         
Altria Group    446,400    31,631,904 
Cadbury Schweppes, ADR    374,000    14,960,000 
Colgate-Palmolive    322,900    18,437,590 
Dean Foods    371,510 a    14,425,733 
PepsiCo    399,600    23,092,884 
Procter & Gamble    544,425    31,369,768 
        133,917,879 
Consumer Services--11.6%         
Accenture, Cl. A    241,880    7,273,332 
Cendant    811,000    14,070,850 
CVS    266,000    7,945,420 
Federated Department Stores    148,800    10,862,400 
Hilton Hotels    640,500    16,307,130 
Home Depot    462,000    19,542,600 
McDonald's    618,000    21,234,480 
News, Cl. A    637,000    10,580,570 
Staples    312,100    7,964,792 
Target    322,930    16,795,589 
Viacom, Cl. B    437,950 a    16,992,460 
Walt Disney    574,700    16,028,383 
        165,598,006 
Energy--12.8%         
Barrick Gold    321,000    8,744,040 
BHP Billiton, ADR    193,600 b    7,714,960 
Chevron    207,000    11,999,790 
Diamond Offshore Drilling    174,000 b    15,573,000 
ENI, ADR    280,000 b    15,954,400 
Exxon Mobil    654,500    39,832,870 
GlobalSantaFe    314,000    19,075,500 
Occidental Petroleum    159,000    14,731,350 
Petroleo Brasileiro, ADR    160,000    13,867,200 
Pride International    285,000 a    8,886,300 
Rio Tinto, ADR    65,000    13,455,000 
XTO Energy    273,100    11,898,967 
        181,733,377 
Financial Services--23.0%         
American International Group    420,000    27,757,800 
AmeriCredit    171,100 a    5,257,903 
Bank of America    866,802    39,474,163 
Bank of New York    661,900    23,854,876 
Capital One Financial    214,100    17,239,332 
CapitalSource    473,660    11,784,661 
CIT Group    93,400    4,998,768 
Citigroup    608,000    28,721,920 
Countrywide Financial    450,000    16,515,000 
Fidelity National Financial    95,900    3,407,327 
Fidelity National Title Group, Cl. A    184,582    4,202,932 
Freddie Mac    313,100    19,099,100 
Goldman Sachs Group    49,400    7,753,824 
JPMorgan Chase & Co.    636,800    26,516,352 
Lehman Brothers Holdings    44,600    6,446,038 
Merrill Lynch & Co.    337,200    26,557,872 
St. Paul Travelers Cos.    159,900    6,682,221 
UnumProvident    497,100 b    10,180,608 
Wachovia    458,100    25,676,505 
Wells Fargo & Co.    220,700    14,096,109 
        326,223,311 
Health Care--10.9%         
Abbott Laboratories    318,000    13,505,460 
AmerisourceBergen    160,810    7,762,299 
Amgen    191,400 a,b    13,924,350 
Fisher Scientific International    166,600 a    11,337,130 
Johnson & Johnson    296,100    17,535,042 
Medtronic    359,700    18,254,775 
Novartis, ADR    275,100    15,251,544 
Pfizer    824,400    20,544,048 
WellPoint    211,300 a    16,360,959 
Wyeth    225,300    10,931,556 
Zimmer Holdings    153,100 a    10,349,560 
        155,756,723 
Technology--13.3%         
Advanced Micro Devices    197,400 a    6,545,784 
Apple Computer    111,600 a    6,999,552 
Broadcom, Cl. A    195,200 a    8,424,832 
Cisco Systems    1,134,003 a    24,573,845 
Citrix Systems    227,000 a    8,603,300 
Hewlett-Packard    622,700    20,486,830 
Intel    583,000    11,281,050 
International Business Machines    342,000    28,204,740 
Microchip Technology    224,000    8,131,200 
Microsoft    1,494,300    40,659,903 
Motorola    316,800    7,257,888 
Qualcomm    359,900    18,214,539 
        189,383,463 
Transportation--1.5%         
Norfolk Southern    382,100    20,660,147 
Utilities--5.2%         
Consolidated Edison    170,000    7,395,000 
Dominion Resources/VA    116,000    8,007,480 
FPL Group    222,000    8,911,080 
Kinder Morgan    94,000    8,647,060 
Sempra Energy    210,000    9,756,600 
Southern    250,000    8,192,500 
Sprint Nextel    315,500    8,152,520 
Verizon Communications    447,000    15,224,820 
        74,287,060 
Total Common Stocks         
(cost $1,126,512,092)        1,420,961,170 


Other Investment--.5%    Shares    Value ($) 



Registered Investment Company;         
Dreyfus Institutional Preferred         
Plus Money Market Fund         
(cost $7,147,000)    7,147,000 c    7,147,000 
 
Investment of Cash Collateral for         
Securities Loaned--.1%    Shares    Value ($) 



Registered Investment Company;         
Dreyfus Institutional Cash         
Advantage Fund         
(cost $1,402,878)    1,402,878 c    1,402,878 
 
Total Investments (cost $1,135,061,970)    100.5%    1,429,511,048 
Liabilities, Less Cash and Receivables    (.5%)    (6,475,682) 
Net Assets    100.0%    1,423,035,366 

ADR - American Depository Receipts
a Non-income producing security.
b All or a portion of these securities are on loan. At March 31, 2006, the total market value of the fund's securities on loan
is $1,343,406 and the total market value of the collateral held by the fund is $1,402,878.
c Investment in affiliated money market mutual fund.
d Security restricted as to public resale. Investments is restricted securities, with a value of $9,622,075 or .68% of net
assets, are as follows:
    Acquisition    Purchase    Net     
Issuer    Date    Price ($)     Assets (%)    Valuation ($) †† 





Galen Partners II, LP (Units)    5/6/94-1/3/97    673,552    .06    673,552 per unit 
SK Equity Fund, LP (Units)    3/8/95-9/18/96    1,155,218    .62    4,951,275 per unit 

  † Average cost per unit.
The valuation of these securities has been determined in good faith under
the direction of the Board of Directors.

Securities valuation policies and other investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the Securities and Exchange Commission on Form N-CSR.


Item 2. Controls and Procedures.

(a) The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 3.    Exhibits. 
 
(a)    Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) 
under the Investment Company Act of 1940. 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

THE DREYFUS FUND INCORPORATED

By:    /s/ Stephen E. Canter 

    Stephen E. Canter 
    President 
Date:    May 23, 2006 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

By:    /s/ Stephen E. Canter 

    Stephen E. Canter 
    Chief Executive Officer 
Date:    May 23, 2006 
 
By:    /s/ James Windels 

James Windels
    Chief Financial Officer 
Date:    May 23, 2006 

EXHIBIT INDEX

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT)